SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 197 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,270,749 | +58.3% | 10,483 | +49.6% | 0.08% | +59.6% |
| Q2 2023 | $802,556 | +66.3% | 7,008 | +100.2% | 0.05% | +79.3% |
| Q1 2023 | $482,543 | +2.9% | 3,501 | -17.4% | 0.03% | +70.6% |
| Q3 2022 | $469,000 | +37.9% | 4,239 | -6.5% | 0.02% | +70.0% |
| Q2 2022 | $340,000 | -5.3% | 4,536 | -1.8% | 0.01% | -9.1% |
| Q2 2021 | $359,000 | -60.5% | 4,621 | -13.3% | 0.01% | -52.2% |
| Q4 2020 | $909,000 | +347.8% | 5,331 | +268.4% | 0.02% | +130.0% |
| Q3 2020 | $203,000 | -88.6% | 1,447 | -87.0% | 0.01% | -89.8% |
| Q2 2020 | $1,782,000 | +912.5% | 11,109 | +517.2% | 0.10% | +716.7% |
| Q1 2020 | $176,000 | -24.5% | 1,800 | 0.0% | 0.01% | +50.0% |
| Q4 2019 | $233,000 | -81.8% | 1,800 | -89.4% | 0.01% | -86.2% |
| Q3 2019 | $1,280,000 | +43.8% | 17,000 | +190.5% | 0.06% | +31.8% |
| Q2 2019 | $890,000 | +182.5% | 5,852 | +121.7% | 0.04% | +144.4% |
| Q1 2019 | $315,000 | +197.2% | 2,640 | +172.4% | 0.02% | +157.1% |
| Q4 2018 | $106,000 | -91.3% | 969 | -87.2% | 0.01% | -90.1% |
| Q3 2018 | $1,222,000 | +34.3% | 7,567 | +10.0% | 0.07% | +22.4% |
| Q2 2018 | $910,000 | -42.7% | 6,879 | -67.9% | 0.06% | -49.6% |
| Q1 2018 | $1,589,000 | -21.9% | 21,449 | -41.3% | 0.12% | -29.4% |
| Q4 2017 | $2,034,000 | -49.2% | 36,561 | -58.6% | 0.16% | -54.7% |
| Q3 2017 | $4,001,000 | +31.8% | 88,226 | -2.0% | 0.36% | +25.4% |
| Q2 2017 | $3,035,000 | +130.6% | 90,053 | +102.5% | 0.29% | +127.8% |
| Q1 2017 | $1,316,000 | +1190.2% | 44,476 | +1094.3% | 0.13% | +950.0% |
| Q4 2016 | $102,000 | -46.3% | 3,724 | +20.1% | 0.01% | -40.0% |
| Q3 2016 | $190,000 | +900.0% | 3,100 | +210.0% | 0.02% | +566.7% |
| Q2 2016 | $19,000 | -75.3% | 1,000 | -50.0% | 0.00% | -75.0% |
| Q4 2015 | $77,000 | -45.4% | 2,000 | -54.5% | 0.01% | -40.0% |
| Q3 2015 | $141,000 | -5.4% | 4,400 | -10.2% | 0.02% | -4.8% |
| Q2 2015 | $149,000 | -5.7% | 4,900 | -58.8% | 0.02% | -4.5% |
| Q1 2015 | $158,000 | -40.6% | 11,900 | -35.3% | 0.02% | -43.6% |
| Q4 2014 | $266,000 | -49.2% | 18,400 | -25.8% | 0.04% | -47.3% |
| Q3 2014 | $524,000 | +21.3% | 24,800 | +71.0% | 0.07% | +29.8% |
| Q2 2014 | $432,000 | -16.8% | 14,500 | -32.9% | 0.06% | -17.4% |
| Q1 2014 | $519,000 | +308.7% | 21,600 | +248.7% | 0.07% | +228.6% |
| Q4 2013 | $127,000 | -80.2% | 6,195 | -54.4% | 0.02% | -79.8% |
| Q3 2013 | $642,000 | +29.7% | 13,595 | +4.6% | 0.10% | -1.9% |
| Q2 2013 | $495,000 | -55.4% | 13,000 | -56.7% | 0.11% | -48.8% |
| Q1 2013 | $1,109,000 | – | 30,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |